Analyst Upgrades

• Alcatel-Lucent (ALU) to buy from neutral at Goldman.
• Nvidia (NVDA) to outperform from market perform at JMP Securities.
• Verizon (VZ), AT&T (T), Leap Wireless (LEAP) and MetroPCS (PCS) to outperform from neutral at RW Baird.
• Illumina (ILMN) to buy from hold at Auriga.
• Sun Bancorp (SNBC) to neutral from sell at Janney Capital.
• American Tower (AMT), SBA Communications (SBAC) and Freeport McMoRan (FCX) to overweight from equal weight at Morgan Stanley.

Analyst Upgrades

• Jefferies upgraded St. Jude (STJ) to buy from hold and raised its target to $49 from $39. The firm cites valuation and the positive impact from the Boston Scientific (BSX) ICD recall for the upgrade. Shares were also upgraded to neutral from sell at Goldman, as the firm sees upside for shares into Q1 results.
• RBC Capital upgraded EMC Corp. (EMC) to outperform from sector perform and raised its target to $22 from $21. The firm upgraded shares based on valuation and believes the company can meet or modestly beat March quarter expectations.
• Auriga upgraded MetroPCS (PCS) to buy from hold as it believes customer migration away from postpaid to prepaid may be accelerating. The firm raised its target for shares to $9 from $7.
• Caterpillar (CAT) was raised to outperform from neutral at Baird.
• Best Buy (BBY) was upgraded to market perform from underperform at FBR Capital.
• Expedia (EXPE) was upgraded to overweight from neutral at Piper Jaffray.

• Citigroup upgraded Procter & Gamble (NYSE:PG) to Buy from Hold after meeting with management as it believes a more aggressive strategy will lead to the company regaining market share. Citi raised its target on shares to $66 from $54.
  
• Piper Jaffray upgraded Allscripts (NASDAQ:MDRX) to Overweight from Neutral after learning the company signed a large contract with North Shore Long Island Jewish Hospital. Piper now sees upside to estimates and raised its target on shares to $22.50 from $14.
  
• UBS upgraded Amedisys (NASDAQ:AMED) to Buy from Neutral following a review of the Senate Finance Committee's healthcare proposal, which they view as "benign." The firm raised its target to $57 from $46.
• Daimler (NYSE:DAI) was upgraded to Outperform from Market Perform at Bernstein.
  
• Boston Private (NASDAQ:BPFH) was upgraded to Outperform from Market Perform at Keefe Bruyette.
  
• E-Trade (NASDAQ:ETFC) was upgraded to Buy from Neutral at Goldman.